Paradoxically, while Notch1 enhances TRAIL sensitivity in hepatocellular carcinoma by stabilizing p53 through Akt/Hdm2 inhibition (109), it cooperates with HIF-1 to promote epithelial-mesenchymal transition (EMT) in breast cancer (108). Here, AKT1 is linked to breast carcinoma.